Clinical translation of immunomodulatory therapeutics
Authors:
- 27 July 2021
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 176, 113896
Abstract
No abstract availableKeywords
Funding Information
- Cancer Prevention and Research Institute of Texas (RR160047, 1842494, 1R01DK120459-01)
- National Science Foundation (RR160047, 1842494, 1R01DK120459-01)
- National Institutes of Health (RR160047, 1842494, 1R01DK120459-01)
This publication has 259 references indexed in Scilit:
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Interleukin-2 Inhibits Germinal Center Formation by Limiting T Follicular Helper Cell DifferentiationImmunity, 2012
- Immunogenicity of Therapeutic Proteins: The Use of Animal ModelsPharmaceutical Research, 2011
- Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineagesNature Immunology, 2011
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate CancerNew England Journal of Medicine, 2010
- Overview of the immune responseJournal of Allergy and Clinical Immunology, 2010
- The role of innate immune responses in autoimmune disease developmentAutoimmunity Reviews, 2009
- Potential chemotherapy side effects: What do oncologists tell parents?Pediatric Blood & Cancer, 2008
- Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?The Lancet Oncology, 2007
- The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine designNature Reviews Immunology, 2006